FibroBiologics, Inc. (FBLG)
NASDAQ: FBLG · Real-Time Price · USD
0.3359
+0.0007 (0.21%)
Nov 7, 2025, 11:04 AM EST - Market open
FibroBiologics Employees
FibroBiologics had 13 employees as of December 31, 2024. The number of employees increased by 3 or 30.00% compared to the previous year.
Employees
13
Change (1Y)
3
Growth (1Y)
30.00%
Revenue / Employee
n/a
Profits / Employee
-$1,423,154
Market Cap
17.28M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 13 | 3 | 30.00% |
| Dec 31, 2023 | 10 | 3 | 42.86% |
| Dec 31, 2022 | 7 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
FBLG News
- 6 days ago - FibroBiologics Reports Third Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 14 days ago - FibroBiologics to Present at Bio-Europe 2025 - GlobeNewsWire
- 24 days ago - FibroBiologics to Present at the 2025 ThinkEquity Conference - GlobeNewsWire
- 6 weeks ago - FibroBiologics to Present at 2025 Cell & Gene Meeting on the Mesa - GlobeNewsWire
- 2 months ago - FibroBiologics Leadership Authors Opinion Editorial Highlighting Fibroblast Cells' Therapeutic Advantages Over Traditional Stem Cell Therapies - GlobeNewsWire
- 2 months ago - FibroBiologics Announces Positive IND-Enabling Updates Demonstrating Potential of Fibroblast Spheroids in Chronic-Relapse Psoriasis Treatment - GlobeNewsWire
- 2 months ago - FibroBiologics Announces Significant Advancements in Bone Marrow Organoid Platform Enabling Development for Cancer and Immune-Related Therapies - GlobeNewsWire
- 2 months ago - FibroBiologics to Present at the H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewsWire